# US 2025/0122483 A1 · Method of Co-Expressing a Sulfatase and a Sulfatase Modifying Factor in a Plant or Plant Cell

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0122483 A1
- Document ID: US20250122483A1
- Status: Published application
- Kind: A1
- Application number: 18/984,148
- Filed: 2024-12-17
- Published: 2025-04-17
- Earliest claimed: 2014-07-11
- Assignees: Biostrategies Lc
- Applicants: Biostrategies Lc
- Inventors: David N. RADIN
- Web page: https://patentgrep.com/patent/US20250122483A1

## CPC

- C12N 9/0051: {acting on a sulfur group of donors (1.8)}
- A61K 38/168: {from plants}
- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- A61K 38/44: Oxidoreductases (1)
- C07K 14/42: Lectins, e.g. concanavalin, phytohaemagglutinin
- C12N 9/16: acting on ester bonds (3.1)
- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C12Y 108/99: with other acceptors (1.8.99)
- C12Y 301/06: Sulfuric ester hydrolases (3.1.6)
- C07K 2319/00: Fusion polypeptide
- C07K 2319/02: containing a signal sequence
- C07K 2319/04: containing an ER retention signal such as a C-terminal HDEL motif
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES

## Abstract

The subject invention concerns materials and methods for treating or preventing disease and conditions associated with various sulfatase enzymes that are defective or that are not properly expressed in a person or animal. In one embodiment, the disease is Sanfilippo A (MPS-IIIA) disease. The subject invention also concerns materials and methods for treating or preventing multiple sulfatase deficiency (MSD) in a person or animal. Compounds of the invention include a fusion protein comprising i) a mammalian sulfatase, or an enzymatically active fragment or variant thereof, and ii) a plant lectin or a binding subunit thereof. In a specific embodiment, the mammalian sulfatase is a human sulfatase, or an enzymatically active fragment or variant thereof. Polynucleotides encoding the fusion proteins are also contemplated for the subject invention. The subject invention also concerns materials and methods for producing proteins of the invention.

## Claims

### Claim 1

A fusion protein comprising i) a mammalian sulfatase, or an enzymatically active fragment or variant thereof, and ii) a plant lectin or a binding subunit thereof; or a fusion protein comprising i) a mammalian sulfatase modifying factor 1 (SUMF1), or an enzymatically active fragment or variant thereof, and ii) a plant lectin or a binding subunit thereof; or a polynucleotide encoding said fusion protein; or
a human SUMF1 protein expressed in plant cells comprising transforming a plant cell with an expression vector comprising a nucleotide sequence for translational expression of the SUMF1 protein linked to a signal sequence directing expression; or a mammalian sulfatase, or an enzymatically active fragment or variant thereof, produced in a plant or plant cell.

### Claim 2 (depends on 1)

The fusion protein according to claim 1, wherein the mammalian sulfatase is N-acetylgalactosamine-6-sulfatase, N-acetylglucosamine-6-sulfatase, N-sulphoglucosamine sulphohydrolase, sulfamidase, extracellular sulfatase Sulf-1 (hSulf1), extracellular sulfatase Sulf-2 (hSulf2), iduronate 2-sulfatase, arylsulfatase A (ASA), arylsulfatase B (ASB), steryl-sulfatase, arylsulfatase D (ASD), arylsulfatase E (ASE), arylsulfatase F (ASF), arylsulfatase G (ASG), arylsulfatase H (ASH), arylsulfatase I (ASI), arylsulfatase J (ASJ), or arylsulfatase K (ASK).

### Claim 3 (depends on 1)

The fusion protein according to claim 1, wherein the mammalian sulfatase comprises the amino acid sequence of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34, or an enzymatically active fragment or variant thereof.

### Claim 4 (depends on 1)

The fusion protein according to claim 1, wherein the plant lectin is a lectin from Table 2 or Table 3 of the specification.

### Claim 5 (depends on 1)

The fusion protein according to claim 1, wherein the plant lectin is the non-toxic subunit of ricin (RTB) or nigrin (NBB).

### Claim 6 (depends on 1)

The fusion protein according to claim 1, wherein the fusion protein comprises an endoplasmic reticulum (ER) retention sequence.

### Claim 7 (depends on 6)

The fusion protein according to claim 6, wherein the ER retention sequence comprises KDEL.

### Claim 8 (depends on 1)

The fusion protein according to claim 1, wherein the mammalian sulfatase is linked to the plant lectin by a linker sequence of amino acids.

### Claim 9 (depends on 1)

The fusion protein according to claim 1, wherein the SUMF1 comprises the amino acid sequence of SEQ ID NO:36, or an enzymatically active fragment or variant thereof.

### Claim 10 (depends on 1)

The human SUMF1 protein of claim 1, wherein the SUMF1 protein shows enzymatic and biological activity with capacity to activate human sulfatases expressed in plant cells.

### Claim 11 (depends on 10)

The human SUMF1 protein of claim 10, wherein the SUMF1 protein activates a sulfatase in plant cells by catalyzing the conversion of a relevant cysteine to a FGly residue required for activating enzymatic activity of the sulfatase.

### Claim 12 (depends on 1)

The fusion protein according to claim 1, wherein the fusion protein comprises the amino acid sequence of any of SEQ ID NOs: 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, or 69, or an enzymatically active fragment or variant thereof; or wherein the fusion protein comprises the amino acid sequence of any of SEQ ID NOs: 71, 73, 75, 77, 79, or 81, or an enzymatically active fragment or variant thereof.

### Claim 13

A method for treating or preventing a disease or condition associated with a sulfatase enzyme or a sulfatase modifying factor 1 (SUMF1) protein in a person or animal, comprising administering to the person or animal a therapeutically effective amount of a SUMF1 protein or a fusion protein having sulfatase activity, and/or an enzymatically active mammalian sulfatase protein having sulfatase activity, comprising co-expressing in a plant or plant cell: (1) a polynucleotide encoding a mammalian sulfatase fusion protein, and/or a polynucleotide encoding a mammalian sulfatase protein; and (2) a polynucleotide encoding a mammalian sulfatase modifying factor 1 (SUMF1) protein or a SUMF1 fusion protein, wherein the expressed sulfatase fusion protein and/or the expressed mammalian sulfatase protein produced by the method is enzymatically activated in the plant or plant cell by the expressed SUMF1 protein or the expressed SUMF1 fusion protein.
